High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.

Saved in:
Bibliographic Details
Title: High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.
Authors: Tomar AS; Department of Ocular Tumor and Orbital Disease, The New York Eye Cancer Center, New York, New York., Finger PT; Department of Ocular Tumor and Orbital Disease, The New York Eye Cancer Center, New York, New York. Electronic address: pfinger@eyecancer.com., Gallie B; The Eye Cancer Clinic, Princess Margaret Cancer Centre, and Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Canada., Kivelä TT; Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Mallipatna A; The Eye Cancer Clinic, Princess Margaret Cancer Centre, and Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Canada; Department of Ocular Oncology, Narayana Nethralaya Eye Hospital, Bangalore, India., Zhang C; Pediatric Oncology Center, Beijing Children's Hospital, Beijing, China., Zhao J; Pediatric Oncology Center, Beijing Children's Hospital, Beijing, China., Wilson MW; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, and Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Brennan RC; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, and Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Burges M; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, and Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Kim J; USC Roski Eye Institute, Keck Medical School, University of Southern California, and The Vision Center at Children's Hospital Los Angeles, Los Angeles, California., Berry JL; USC Roski Eye Institute, Keck Medical School, University of Southern California, and The Vision Center at Children's Hospital Los Angeles, Los Angeles, California., Jubran R; USC Roski Eye Institute, Keck Medical School, University of Southern California, and The Vision Center at Children's Hospital Los Angeles, Los Angeles, California., Khetan V; Department of Vitreoretina Services, Sankara Nethralaya, Chennai, Tamil Nadu, India., Ganesan S; Department of Vitreoretina Services, Sankara Nethralaya, Chennai, Tamil Nadu, India., Yarovoy A; Ocular Oncology Department, The S.N. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation., Yarovaya V; Ocular Oncology Department, The S.N. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation., Kotova E; Ocular Oncology Department, The S.N. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation., Volodin D; Ocular Oncology Department, The S.N. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation., Yousef YA; Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman, Jordan., Nummi K; Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Ushakova TL; SRI of Pediatric Oncology and Hematology, N.N. Blokhin National Medical Research Center Oncology of Russian Federation, Moscow, Russian Federation; Department of Ophthalmology, Medical Academy of Postgraduate Education, Moscow, Russian Federation., Yugay OV; SRI of Pediatric Oncology and Hematology, N.N. Blokhin National Medical Research Center Oncology of Russian Federation, Moscow, Russian Federation., Polyakov VG; SRI of Pediatric Oncology and Hematology, N.N. Blokhin National Medical Research Center Oncology of Russian Federation, Moscow, Russian Federation; Department of Ophthalmology, Medical Academy of Postgraduate Education, Moscow, Russian Federation., Ramirez-Ortiz MA; Department of Ophthalmology, Hospital Infantil de México Federico Gómez, Mexico City, Mexico., Esparza-Aguiar E; Department of Ophthalmology, Hospital Infantil de México Federico Gómez, Mexico City, Mexico., Chantada G; Precision Medicine Coordination Hospital JP Garrahan, and CONICET, National Scientific and Technical Research Council, Buenos Aires, Argentina; Hemato-Oncology Service, Hospital Sant Joan de Déu, Barcelona, Spain., Schaiquevich P; Precision Medicine Coordination Hospital JP Garrahan, and CONICET, National Scientific and Technical Research Council, Buenos Aires, Argentina., Fandino A; Ophthalmology Service, Hospital JP Garrahan, Buenos Aires, Argentina., Yam JC; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong., Lau WW; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong., Lam CP; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong., Sharwood P; Save Sight Institute, Discipline of Ophthalmology, Sydney Medical School, University of Sydney, Sydney, Australia., Moorthy S; KK Women's and Children's Hospital, Singapore, Republic of Singapore., Long QB; KK Women's and Children's Hospital, Singapore, Republic of Singapore., Essuman VA; Ophthalmology Unit, Department of Surgery, University of Ghana Medical School, College of Health Sciences, University of Ghana, Accra, Ghana., Renner LA; Department of Child Health, University of Ghana Medical School, College of Health Sciences, University of Ghana, Accra, Ghana., Semenova E; Department of Ocular Tumor and Orbital Disease, The New York Eye Cancer Center, New York, New York., Català-Mora J; Retinoblastoma Unit, Department of Ophthalmology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Correa-Llano G; Retinoblastoma Unit, Department of Ophthalmology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Carreras E; Retinoblastoma Unit, Department of Ophthalmology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
Corporate Authors: American Joint Committee on Cancer Ophthalmic Oncology Task Force
Source: Ophthalmology [Ophthalmology] 2022 Aug; Vol. 129 (8), pp. 923-932. Date of Electronic Publication: 2022 Apr 15.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-4713
DOI:10.1016/j.ophtha.2022.04.006